(Pyrimidin-5-yl)boronic acid → 3-(3,5-Difluorophenyl)-6-(2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy)-2-(pyrimidin-5-yl)-1H-inden-1-one
Reaction equation
Br[C:2]1[C:3](=[O:32])[C:4]2[C:9]([C:10]=1[C:11]1[CH:16]=[C:15]([F:17])[CH:14]=[C:13]([F:18])[CH:12]=1)=[CH:8][CH:7]=[C:6]([O:19][CH2:20][CH2:21][N:22]1[CH2:27][CH2:26][N:25]([S:28]([CH3:31])(=[O:30])=[O:29])[CH2:24][CH2:23]1)[CH:5]=2.O1CCN(CCOC2C=C3C(C(C4C=CC=CC=4)=C(Br)C3=O)=CC=2)CC1.[N:59]1[CH:64]=[C:63](B(O)O)[CH:62]=[N:61][CH:60]=1>>[F:17][C:15]1[CH:16]=[C:11]([C:10]2[C:9]3[C:4](=[CH:5][C:6]([O:19][CH2:20][CH2:21][N:22]4[CH2:23][CH2:24][N:25]([S:28]([CH3:31])(=[O:29])=[O:30])[CH2:26][CH2:27]4)=[CH:7][CH:8]=3)[C:3](=[O:32])[C:2]=2[C:63]2[CH:64]=[N:59][CH:60]=[N:61][CH:62]=2)[CH:12]=[C:13]([F:18])[CH:14]=1Participants
4
Reactant 3
Product 1
Procedure
The procedure of Step 7 of Example 1 was repeated except for using 2-bromo-3-(3,5-difluorophenyl)-6-[2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy]-1H-inden-1-one obtained in Step 1 of Example 50 as a starting material instead of 6-(2-morpholinoethoxy)-2-bromo-3-phenyl-1H-inden-1-one, and 5-pyrimidinylboronic acid instead of 3-pyridinylboronic acid, and being purified by prep HPLC (CH3CN/H2O=7:3) to obtain the title compound (34%).
Workup
- custombeing purified by prep HPLC (CH3CN/H2O=7:3)
Sources & evidence
- ORD record
- ord-1b19aa00c876494593cc826b6c5833dc
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08877747B2
Reaction notes
Loading…